Cargando…
Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by a poor prognosis, with a progressive decline in lung function and considerable variability in the disease’s natural history. Besides lung transplantation (LTx), the only available treatments are anti-fibrosing drugs, which have show...
Autores principales: | Manzetti, Gian Marco, Hosein, Karishma, Cecchini, Matthew J., Kwan, Keith, Abdelrazek, Mohamed, Zompatori, Maurizio, Rogliani, Paola, Mura, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645123/ https://www.ncbi.nlm.nih.gov/pubmed/34863146 http://dx.doi.org/10.1186/s12890-021-01753-7 |
Ejemplares similares
-
Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
por: Taha, Nada, et al.
Publicado: (2020) -
Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival
por: Keow, Jonathan, et al.
Publicado: (2022) -
Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis
por: Cecchini, Matthew J., et al.
Publicado: (2018) -
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
por: Manzetti, Gian Marco, et al.
Publicado: (2023) -
Effects of SARS-CoV-2 Infection on Pulmonary Function Tests and Exercise Tolerance
por: Ora, Josuel, et al.
Publicado: (2022)